Laddar...
Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
PURPOSE: Tamoxifen (TAM) is a non-steroidal antiestrogen drug, used in the prevention and treatment of all stages of hormone-responsive breast cancer. Simvastatin (SIM) is a lipid-lowering agent and has been shown to inhibit cancer cell growth. The study aimed to investigate the effect of the combin...
Sparad:
| I publikationen: | Cancer Manag Res |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6886548/ https://ncbi.nlm.nih.gov/pubmed/31819634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S218668 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|